Friday, August 27, 2021 2:01:27 PM
"In order to prevent honest investors from being mislead, it should be noted that NRx announced in May 2021 that it provided the same Clinical Study Report to RLF as it provided to the US FDA. Patients must always come first." -----------wrote JJ ago few minutes
and a reminder - RLF has had ADVITA from Germany in its portfolio for several months. This treasure has long owned protected patent rights over inhalation of aviptadil......why should RLF pay 4 million?
In Europe we see this situation very relaxed!
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
